ATS View
한국어

Proteina KRX:468530KOSDAQ

프로티나 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h0
Articles, 7 days10
DART filings, 7 days0
Articles tracked23since Sep 11

In Q2 2026, Proteina reported revenue of ₩349m, down 63.8% year on year, and an operating loss of ₩4.0bn. Proteina (프로티나) appeared in 10 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 29 with 9 articles. The most common catalyst was contracts & orders (5). It was most often mentioned alongside 글로벌테크놀로지.

Filing signals 4 quarters of losses Screener

Proteina quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩349m-63.8%−₩4.0bn−₩3.1bn
Q1 2026₩169m-84.1%−₩4.7bn−₩3.3bn
Q4 2025 derived₩343m-54.6%−₩4.4bn−₩3.0bn
Q3 2025₩582m-25.4%−₩2.9bn−₩2.6bn
Q2 2025₩964m+26.3%−₩2.4bn
margin −248.8%		−₩2.0bn
Q1 2025₩1.1bn–−₩1.6bn
margin −148.4%		−₩1.4bn
Q4 2024 derived₩757m–−₩2.7bn−₩1.8bn
Q3 2024₩781m–−₩2.0bn
margin −257.5%		−₩1.5bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Proteina top stories 2 weeks, by number of outlets

  1. 1
    프로티나, 골관절염 치료제 후보물질 글로벌 특허 확대
    4 outlets · 4 articlesFirst report Oct 29 09:07 뉴스핌글로벌테크놀로지
  2. 2
    프로티나, 日제약사 2곳과 골관절염 치료제 기술이전 논의
    1 outlets · 1 articlesFirst report Oct 29 10:40 서울경제Licensing deal
  3. 3
    프로티나, 골관절염 신약 특허 확대…日 기술이전 협의
    1 outlets · 1 articlesFirst report Oct 29 14:08 메디파나뉴스Licensing deal
  4. 4
    프로티나, 자체 파이프라인 글로벌 특허 확대…"기술이전 논의 본격화"
    1 outlets · 1 articlesFirst report Oct 29 09:09 프라임경제Licensing deal글로벌테크놀로지
  5. 5
    프로티나, 자체 개발 골관절염 치료제 글로벌 특허망 구축…日 제약사와 기술이전 타진
    1 outlets · 1 articlesFirst report Oct 29 09:31 이투데이Licensing deal글로벌테크놀로지
  6. 6
    프로티나, 골관절염 신약 특허 확대…日 제약사 2곳과 기술 이전 실사
    1 outlets · 1 articlesFirst report Oct 29 13:54 조선비즈

Latest Proteina news Korean headlines